FIELD: chemistry.
SUBSTANCE: invention describes novel 1,2,3-triazole derivatives of general formula: 
, where X denotes O or N-OH; R1 is hydrogen, fluorine, chlorine, bromine, phenyl or C1-4-alkyl, unsubstituted or substituted 1-3 times with fluorine, chlorine and bromine; R2 - R5 hydrogen; pharmaceutically acceptable salts and stereoisomers thereof and a pharmaceutical composition containing the said compounds.
EFFECT: obtaining compounds which can be used as oestrogen receptor selective modulators for treating or preventing different conditions related to oestrogen function, including: bone loss, bone fracture, osteoporosis, metastatic bone disease, Piaget's disease, periodontal disease etc.
5 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRICYCLIC TRIAZOLIC COMPOUNDS | 2014 |
|
RU2666728C2 |
| CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
| NEW IMIDAZO[4,5-c]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS | 2018 |
|
RU2773516C2 |
| NOVEL INTERMEDIATE COMPOUNDS FOR PRODUCING TRIAZOLO(4,5-d)PYRIMIDINE | 2012 |
|
RU2593201C2 |
| DIAZEPANE SUBSTITUTED COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | 2007 |
|
RU2458924C2 |
| SUBSTITUTED 2-ACYL-2-AMINOTHIAZOLES | 2005 |
|
RU2371438C2 |
| REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
| COMPOUNDS OF SUBSTITUTED DIAZEPANES AS ANTAGONISTS OF OREXIN RECEPTORS | 2007 |
|
RU2561727C2 |
| NOVEL TRIAZOLE COMPOUNDS | 2011 |
|
RU2588137C2 |
| CONFORMATIONALLY RESTRICTED PI3K AND MTOR INHIBITORS | 2014 |
|
RU2669696C2 |
